Does a normal TSH and free T4 with low free T3 indicate reduced peripheral T4-to-T3 conversion?

The biochemical pattern of a normal Thyroid Stimulating Hormone (TSH) and free T4 (fT4) alongside a low free T3 (fT3) is a recognized clinical indicator of impaired thyroid hormone metabolism at the peripheral level. While TSH is the primary marker for pituitary-thyroid feedback, it may not always reflect the metabolic state of peripheral tissues.

Mechanistic evidence

The physiological basis for this pattern lies in the deiodination process, where the pro-hormone T4 is converted into the biologically active T3.

• Deiodinase enzymes: Approximately 80% to 90% of circulating T3 is produced through the removal of an iodine atom from T4 by Type 1 (DIO1) and Type 2 (DIO2) deiodinases. A reduction in the activity of these enzymes—due to nutritional deficiencies, chronic inflammation, or genetic polymorphisms—directly leads to lower fT3 levels despite adequate fT4 substrate.
• Genetic variants: Research into the DIO2 Thr92Ala polymorphism has shown that individuals with specific genetic variations exhibit reduced intracellular T4-to-T3 conversion. In these cases, patients may maintain a normal TSH because the pituitary has its own localized deiodinase system (primarily DIO2) that can remain sensitive to circulating T4, even when other tissues are experiencing a T3 deficit.
• Tissue-level activation: Because T3 is the form that binds to nuclear thyroid receptors to initiate gene transcription, a low fT3 level represents a functional reduction in thyroid hormone signaling. This state is sometimes referred to as "tissue hypothyroidism," where the "thermostat" (the pituitary) is satisfied, but the "rooms" (peripheral tissues like muscle and liver) are under-activated.

Clinical and metabolic findings

This pattern has significant implications for metabolic health and symptom management, particularly in patients who appear "biochemically euthyroid" by TSH standards alone.

• Metabolic rate: Studies in euthyroid populations indicate that a lower fT3/fT4 ratio is associated with a lower resting energy expenditure (REE) and markers of metabolic syndrome. This suggests that even within the "normal" range, the efficiency of T4 to T3 conversion influences overall metabolic rate.
• Treatment discordance: In patients receiving levothyroxine (T4-only) therapy, a subset of individuals fails to achieve normalized fT3 levels despite a normal TSH. Research suggests these patients often report persistent symptoms of hypothyroidism, such as fatigue and cognitive "fog," which may stem from the failure to restore T3 concentrations at the cellular level.
• Non-thyroidal illness: This pattern is also classic for "Euthyroid Sick Syndrome," where systemic illness, caloric restriction, or high stress leads to a downregulation of peripheral deiodinases as an adaptive mechanism to conserve energy.

Bottom line

A lab profile showing normal TSH/fT4 with low fT3 is scientifically consistent with reduced peripheral conversion of T4 to T3 and suboptimal tissue-level thyroid activation. This pattern identifies a functional thyroid deficiency that standard TSH screening may overlook, emphasizing the role of deiodinase efficiency in systemic metabolic health.